Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Psoriatic Arthritis: Recognize, Manage Comorbidities

Karen Appold  |  Issue: May 2015  |  May 15, 2015

Regardless of who performs the testing, communicating with the patient and the patient’s primary care physician about medical comorbidities associated with PsA is critical.

“Patients should be aware of the association with cardiovascular disease in particular so that they are empowered to participate in their own care and advocate for routine screening with their primary care physician,” Dr. Ogdie-Beatty says. “It is equally important for a rheumatologist to communicate with the patient’s primary care physician because most are unable to keep up with the literature in the many areas of medicine. Thus, we need to inform them of what they should be watching for, partner with them in performing screening tests and stay on the same page with regard to PsA management.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Notable Comorbidities

Among the 13 comorbidities highlighted in the review, cardiovascular disease and diabetes may have the greatest impact on a patient’s life, Dr. Ogdie-Beatty says, so it’s worth paying the closest attention to these conditions. Additionally, there are existing screening guidelines for the general population for these diseases that either the rheumatologist or the primary care physician can facilitate.

Dr. Husni also would advise patients to see an ophthalmologist if they experience symptoms, such as eye dryness, redness, pain or vision loss. “Patients may not realize that there can be a relationship between PsA and eye disease,” she says.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In addition, Dr. Ruderman says it’s important to focus on the comorbidities that are both very common and potentially treatable, notably hyperlipidemia and atherosclerosis, diabetes, obesity and depression. “Recognizing those diseases, such as uveitis and inflammatory bowel disease, that are as much associated conditions as comorbidities, is also very important,” he continues.

Elinor A. Mody, MD, director, Women’s Orthopedic and Joint Disease Program, Brigham and Women’s Hospital, Boston, who also commented on the review, singled out depression as a comorbidity to watch for. “This is a condition that we aren’t as good at screening for,” she says. “So be sure to alert the patient’s primary care physician if you don’t screen for it yourself.” Psoriasis is associated with increased risk of suicide and alcoholism.

Rethinking Treatments

Being aware of comorbidities is crucial when prescribing medications. In particular, nonsteroidal antiinflammatory drugs (NSAIDs) should be prescribed with caution in patients with PsA and certain other conditions. NSAIDs can cause elevated liver transaminases (particularly in the setting of existing liver disease); may cause flares in Crohn’s disease and ulcerative colitis; may increase the risk of cardiovascular events, such as stroke or myocardial infarction, in patients with existing cardiovascular disease; may cause fluid retention or decompensation in congestive heart failure; and may be problematic in patients with chronic kidney disease because they are linked to increased risk for acute kidney injury or worsening kidney disease.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:comorbiditiespatient carePsoriatic Arthritisrheumatologist

Related Articles

    Psoriatic Arthritis & the Obese Patient

    November 6, 2022

    Estimates from the National Psoriasis Foundation indicate that more than 8 million people in the U.S. suffer from psoriasis and that approximately 30% of those individuals develop psoriatic arthritis (PsA).1 Given these statistics, roughly 2.4 million people in the country are likely affected by PsA. Moreover, patients with this systemic condition carry a higher-than-average burden…

    Psoriatic Arthritis: Advances in Therapeutics, Imaging & More Presented at ACR Convergence 2022

    December 1, 2022

    PHILADELPHIA—Selecting my top 10 picks for abstracts in psoriatic arthritis (PsA) at the ACR Convergence 2022 meeting was not easy because there was a great deal to review and learn from the 139 abstracts submitted to the meeting. I focused first and foremost on advances in therapeutics that encompassed both new and approved therapeutics, novel…

    Late Spring 2021’s Awards, Appointments & Announcements in Rheumatology

    April 17, 2021

    AMA Honors Mark Andrejeski with Lifetime Achievement Award In November 2020, the American Medical Association (AMA) presented Mark Andrejeski, the recently retired executive vice president of the ACR, with its Medical Executive Lifetime Achievement Award. The award honors a medical association executive who has contributed substantially to the goals and ideals of the medical profession….

    Case Report: A Psoriatic Arthritis Patient with Dactylitis & Enthesitis

    September 20, 2018

    A 36-year-old woman presented at the Johns Hopkins Arthritis Center for a second opinion regarding a diagnosis of psoriatic arthritis (PsA). One year prior to our evaluation, she had developed pain and stiffness in her hands, feet, knees, ankles, elbows and shoulders. She had mild plaque psoriasis of the scalp and base of the neck,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences